Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net loss $ (9,035,292) $ (17,525,056)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 25,176 25,985
Stock-based compensation expense 1,354,901 1,022,255
Stock issued for purchase of Noachis Terra 8,030,699
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 256,189 274,581
Accounts payable and accrued expenses 993,251 (484,159)
Net cash used in operating activities (6,405,775) (8,655,695)
Cash flows from financing activities:    
Borrowings under short-term notes payable 132,088
Payments on short-term notes payable (228,227) (143,864)
Redemption of Series C Preferred stock (5,635,672)
Proceeds from issuance of common stock for stock option exercise 267,140
Proceeds from issuance of common stock for warrant exercise 2,261,336 28,500
Net proceeds from issuance of common stock 26,676,392
Net cash provided by financing activities 23,340,969 16,724
Net increase (decrease) in cash and cash equivalents 16,935,194 (8,638,971)
Cash and cash equivalents at beginning of period 17,639,575 18,267,994
Cash and cash equivalents at end of period 34,574,769 9,629,023
Supplemental disclosure of cash flow information:    
Interest paid 3,601 2,387
Non-cash investing and financing activities:    
Stock dividend on Series C preferred stock $ 1,117,531 $ 661,458